Specialty Networks reposted this
Featured article of the week! Written by Specialty Networks members Caroline Branch, Daniel Canter, and Gautam Jayram; Management of Adverse Events From Checkpoint Inhibitors in Urologic Practice: Where Are We Today? Members of the urology community are becoming increasingly interested in being more active participants in urologic cancer care. Recent survey data from independent group urology meetings have suggested that 20% of large community-based urology groups are currently administering checkpoint inhibitor therapies in their practice, and up to 50% are interested in doing so in the near future. Read the full article here: https://lnkd.in/eJ5Qdvjd